Form 4: Evoke Pharma Director Cam L. Garner Acquires 17,750 Stock Options

Director Cam L. Garner acquired 17,750 stock options in Evoke Pharma Inc. on May 22, 2024, at an exercise price of $0.451.

Summary

• On May 22, 2024, Cam L. Garner, a director of Evoke Pharma Inc., acquired 17,750 stock options.
• The options have an exercise price of $0.451.
• These options vest on the one-year anniversary of the grant date, contingent upon Garner's continued service to Evoke Pharma.
• The expiration date for these options is May 21, 2034.
• Following the transaction, Garner directly owns 17,750 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition by a director. It indicates confidence but doesn't provide specific financial insights.

Positives

• The acquisition of stock options by a director signals confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The acquisition of stock options by a director can positively influence shareholder confidence.

Key Dates

Keywords

Evoke Pharma, Stock Options, Director, Form 4, Beneficial Ownership, Cam L. Garner